Antidepressants PGx test

We are pleased to announce that Asper Biogene has launched a new pharmacogenetic test – Antidepressants PGx – for assessing metabolic response to antidepressant medications.

Antidepressants PGx test includes carefully selected and strictly evidence-based genetic markers. The test provides dosing recommendations for selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs) based on guidelines published by Clinical Pharmacogenetics Implementation Consortium (CPIC). Read more at www.asperbio.com/asper-pharmacogenetics/antidepressants-pgx/